Seagen Inc.
BCMA antibodies and use of same to treat cancer and immunological disorders
Last updated:
Abstract:
The invention provides humanized antibodies that specifically bind to BCMA. The antibodies are useful for treatment and diagnoses of various cancers and immune disorders as well as detecting BCMA.
Status:
Grant
Type:
Utility
Filling date:
14 May 2019
Issue date:
3 Aug 2021